Torrent Pharmaceuticals Performance
52 Week Range
- Open Price
- Previous Close
Start SIP in TORRENT PHARMACEUTICALSStart SIP
Torrent Pharmaceuticals Share Price
Torrent Pharmaceuticals Investment Rating
Torrent Pharmaceuticals has an operating revenue of Rs. 8,877.00 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
|Indicator||Sep 2022||Jun 2022||Mar 2022||Dec 2021||Sep 2021||Jun 2021||Mar 2021|
|Oper Rev Qtr Cr||1,928||1,933||1,662||1,588||1,799||1,681||1,443|
|Operating Expenses Qtr Cr||1,308||1,268||1,179||1,161||1,182||1,117||1,037|
|Operating Profit Qtr Cr||620||665||483||427||617||578||431|
|Depreciation Qtr Cr||156||149||147||152||153||150||152|
|Interest Qtr Cr||62||51||52||57||64||66||69|
|Tax Qtr Cr||141||167||124||85||128||138||22|
|Net Profit Qtr Cr||272||327||221||170||326||274||279|
Torrent Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- Bearish Moving Average
- 20 Day
- 50 Day
- 100 Day
- 200 Day
- 20 Day
- 50 Day
- 100 Day
- 200 Day
Torrent Pharmaceuticals Resistance and Support
|MACD Single Line||7.18|
Torrent Pharmaceuticals Delivery and Volume
|Period||NSE + BSE Volume Avg||NSE + BSE Delivery Volume Avg||NSE + BSE Delivery Volume %|
Torrent Pharmaceuticals Result Highlights
Torrent Pharmaceuticals Synopsis
NSE-Medical-Generic DrugsTorrent Pharmac is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 6742.32 Cr. and Equity Capital is Rs. 84.62 Cr. for the Year ended 31/03/2022. Torrent Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/07/1972 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1972PLC002126 and registration number is 002126.
|Shares in Float||9.81|
|No of funds||559|
|U/D Vol ratio||1.3|
|LTDebt / Equity||31|
|Foreign Portfolio Investors||11.37%||10.79%||10.8%|
|Financial Institutions/ Banks|
Torrent Pharmaceuticals Management
|Mr. Sudhir Mehta||Chairman Emeritus|
|Mr. Samir Mehta||Executive Chairman|
|Mr. Shailesh Haribhakti||Independent Director|
|Mr. Haigreve Khaitan||Independent Director|
|Ms. Ameera Shah||Independent Director|
|Ms. Nayantara Bali||Independent Director|
|Dr. Maurice Chagnaud||Independent Director|
|Mr. Jinesh Shah||Director - Operations|
|Mr. Manish Mahendra Choksi||Independent Director|
|Mr. Aman Samir Mehta||Whole Time Director|
Torrent Pharmaceuticals Forecast
Torrent Pharmaceuticals Corporate Action
|2022-05-25||Audited Results, Dividend & Bonus issue|
|2022-01-25||Quarterly Results & Interim Dividend|
|2022-06-06||FINAL||Rs.8.00 per share(160%)Final Dividend|
|2022-06-06||SPECIAL||Rs.15.00 per share(300%)Special Dividend|
|2022-02-03||INTERIM||Rs.25.00 per share(500%)Interim Dividend|
|2021-06-18||FINAL||Rs.15.00 per share(300%)Final Dividend|
|2021-02-16||INTERIM||Rs.20.00 per share(400%)Interim Dividend|
|2022-07-11||Bonus||Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 5/-.|
Torrent Pharmaceuticals FAQs
What is Share Price of Torrent Pharmaceuticals ?
Torrent Pharmaceuticals share price is ₹1615 As on 07 December, 2022 | 06:13
What is the Market Cap of Torrent Pharmaceuticals ?
The Market Cap of Torrent Pharmaceuticals is ₹54664 Cr As on 07 December, 2022 | 06:13
What is the P/E ratio of Torrent Pharmaceuticals ?
The P/E ratio of Torrent Pharmaceuticals is 68.6 As on 07 December, 2022 | 06:13
What is the PB ratio of Torrent Pharmaceuticals ?
The PB ratio of Torrent Pharmaceuticals is 9.2 As on 07 December, 2022 | 06:13
What were the company's most recent reported sales and net income?
Torrent Pharmaceuticals Ltd recorded a net sales of INR 8508 crores in the year ending March 2022.
What is the future of the company's shares?
Torrent Pharmaceuticals Ltd stock is a good option for long-term investment since the stock prices indicate a strong buying trend.